Pulse Biosciences, Inc.
PLSE
$21.42
$0.492.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.78M | -74.73M | -68.03M | -60.24M | -53.59M |
| Total Depreciation and Amortization | 1.07M | 1.10M | 1.14M | 1.16M | 1.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.61M | 24.21M | 21.57M | 18.44M | 14.52M |
| Change in Net Operating Assets | -5.02M | 914.00K | 821.00K | 560.00K | 1.55M |
| Cash from Operations | -54.12M | -48.51M | -44.50M | -40.08M | -36.34M |
| Capital Expenditure | -315.00K | -263.00K | -239.00K | -165.00K | -125.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.00K | -20.00K | -20.00K | -- | -- |
| Cash from Investing | -335.00K | -283.00K | -259.00K | -165.00K | -125.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.15M | 65.03M | 124.91M | 124.92M | 110.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -59.00K | -3.00K | -281.00K | -281.00K |
| Cash from Financing | 17.15M | 64.98M | 124.91M | 124.64M | 110.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.30M | 16.18M | 80.15M | 84.39M | 73.67M |